Patents Assigned to BEIJING DIACRID MEDICAL TECHNOLOGY CO., LTD.
  • Patent number: 8765181
    Abstract: The present invention provides a nano-micellar preparation containing vinca alkaloids antitumor agent for intravenous injection, which cincludes a therapeutically effective amount of vinca alkaloids antitumor agent (vinblastine, vincristine, vindesine and vinorelbine), a phosphatide derivatized with polyethylene glycol, together with pharmaceutically acceptable adjuvants. The preparation is prepared by encapsulating the medicament with a nano-micelle to obtain the nano-micellar preparation containing vinca alkaloids antitumor agent for injection. The vinca alkaloids antitumor agent and the phosphatide derivatized with polyethylene glycol form a nano-micelle with a highly uniform particle size.
    Type: Grant
    Filed: September 8, 2006
    Date of Patent: July 1, 2014
    Assignee: Beijing Diacrid Medical Technology Co., Ltd
    Inventors: Wei Liang, Min'an Lou, Wei Si
  • Publication number: 20090053293
    Abstract: The present invention provides a nano-micellar preparation containing vinca alkaloids antitumor agent for intravenous injection, which cincludes a therapeutically effective amount of vinca alkaloids antitumor agent (vinblastine, vincristine, vindesine and vinorelbine), a phosphatide derivatized with polyethylene glycol, together with pharmaceutically acceptable adjuvants. The preparation is prepared by encapsulating the medicament with a nano-micelle to obtain the nano-micellar preparation containing vinca alkaloids antitumor agent for injection. The vinca alkaloids antitumor agent and the phosphatide derivatized with polyethylene glycol form a nano-micelle with a highly uniform particle size.
    Type: Application
    Filed: September 8, 2006
    Publication date: February 26, 2009
    Applicant: BEIJING DIACRID MEDICAL TECHNOLOGY CO., LTD.
    Inventors: Wei Liang, Min'an Lou, Wei Si